长春高新：苯磺酸氨氯地平口服溶液用冻干粉在美国获批上市

Core Viewpoint - Changchun High New's subsidiary, Brillian Pharma INC., has received FDA approval for its Amlodipine Besylate Oral Solution Lyophilized Powder, indicating a significant advancement in its product portfolio and potential market opportunities in the hypertension and chronic stable angina treatment sectors [1] Group 1: Product Approval - The FDA has approved the Amlodipine Besylate Oral Solution Lyophilized Powder for use in patients aged 6 and above, as well as adults [1] - The product is indicated for the treatment of hypertension and chronic stable angina, including vasospastic angina and coronary heart disease confirmed by angiography [1]